The Science and Technology Pole stems from a collaboration agreement between MultiMedica Group; the Biomedical Technologies Institute, National Research Council, Milan (ITB); the NRC (CNR) Department  of Molecular Design; the Excellence Center of the University of Milan CISI - Interdisciplinary bio-molecular and industrial application Research Center; BioRep and numerous organizations operating in the biotech, life science and nanoscience sectors.

“Our Vision”
Operating by consistently adopting interdisciplinary approaches in combination with highly qualified public and private operators as an outpost of biological and biomedical knowledge, with the objective of contributing to the advancement of medical science, of expanding current knowledge to improve diagnosis, treatment and rehabilitation processes, to develop new biomedical and biotechnology products and services, and to accelerate the transition of medical practice from curative to preventive and prognostic.

Mission:
Implement this vision by basing activities on four interdependent elements:

• enhance biomedical and biotechnological expertise to excellence levels by promoting and performing scientific research
• conveying it through training and education programs tailored to healthcare and research staff
• dissemination across family doctors and healthcare facilities, internal and external Foundation researchers through highly advanced information and communication technologies, “spin off” training programs and running business organization incubation and acceleration activities
• use within medical practice and biomedical and biotechnology innovation through the development and enhancement of products, processes and services which originate from the research activity.

The Pole’s areas of activity
- The first area of activity focuses on using combinatorial chemistry and biotechnology to discover and characterize new biologically active molecules.
- The second area of activity focuses on identifying new molecular target drugs through high performance sequencing of gene clusters in healthy and ill individuals. The areas of interest include cardiovascular, schizophrenia, tumors
- The third activity area is focused on studying the correlation between individual genetic heritage and drug effectiveness (Pharmacogenomics)
- The fourth area focuses on the isolation, analysis and use of adult or umbilical cord stem cells for human disease treatments.
- The fifth area is related to storing and preserving biological matter at low temperatures using biorepositories capable of preserving biological material in liquid nitrogen or in freezers.